{"text": ["Tilray", "(TLRY)", "to", "Report", "Q4", "Earnings:", "What's", "in", "the", "Cards?"], "created_at": "2021-07-23 20:47:08"}
{"text": ["AbbVie", "(ABBV)", "Earnings", "Expected", "to", "Grow:", "What", "to", "Know", "Ahead", "of", "Next", "Week's", "Release"], "created_at": "2021-07-23 19:00:07"}
{"text": ["AbbVie's", "Dalvance", "For", "Bacterial", "Skin", "Infection", "Gets", "FDA", "Approval", "For", "Pediatric", "Patients"], "created_at": "2021-07-23 18:57:26"}
{"text": ["10", "Best", "Dividend", "Aristocrats", "to", "Buy", "According", "to", "Hedge", "Funds"], "created_at": "2021-07-23 17:11:32"}
{"text": ["DALVANCE\u00ae", "(dalbavancin)", "Receives", "FDA", "Approval", "to", "Treat", "Acute", "Bacterial", "Skin", "and", "Skin", "Structure", "Infections", "in", "Pediatric", "Patients"], "created_at": "2021-07-23 16:37:00"}
{"text": ["Why", "AbbVie", "(ABBV)", "Could", "Beat", "Earnings", "Estimates", "Again"], "created_at": "2021-07-23 16:10:04"}
{"text": ["Pharma", "Stock", "Roundup:", "JNJ,", "NVS", "Q2", "Earnings,", "PFE,", "ABBV,", "LLY", "&", "MRK", "FDA", "Updates"], "created_at": "2021-07-23 12:01:12"}
